Eagle Veterinary Technology Co.Ltd (044960) — Capital Reinvestment Ratio

Latest as of June 2025: 0.00x

Eagle Veterinary Technology Co.Ltd (044960) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩1.46 Billion) in capital expenditures (₩7.08 Million). See free cash flow generation of Eagle Veterinary Technology Co.Ltd to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

₩1.46 Billion
KRW

Capital Expenditures

₩7.08 Million
KRW

Data as of

Jun 2025
Most recent filing

Eagle Veterinary Technology Co.Ltd Capital Reinvestment Ratio (2014–2024)

This chart tracks Eagle Veterinary Technology Co.Ltd's Capital Reinvestment Ratio across 9 annual periods.

Annual Capital Reinvestment Ratio for Eagle Veterinary Technology Co.Ltd (2014–2024)

Year-by-year Capital Reinvestment Ratio for Eagle Veterinary Technology Co.Ltd from 2014 to 2024. For live market cap and broader valuation context, see market value of Eagle Veterinary Technology Co.Ltd.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2024 0.65x ₩4.34 Billion ₩2.83 Billion ▼ -31.9%
2023 0.96x ₩4.89 Billion ₩4.69 Billion ▲ +3068.3%
2021 0.03x ₩6.13 Billion ₩185.59 Million ▼ -77.3%
2020 0.13x ₩5.90 Billion ₩784.87 Million ▲ +2.7%
2019 0.13x ₩2.92 Billion ₩378.68 Million ▼ -79.2%
2018 0.62x ₩2.02 Billion ₩1.26 Billion ▼ -82.7%
2017 3.61x ₩511.60 Million ₩1.84 Billion ▲ +1395.4%
2016 0.24x ₩3.13 Billion ₩754.08 Million ▼ -96.7%
2014 7.40x ₩1.87 Billion ₩13.85 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow